Synthetic DNA Sequences
The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to GenScript USA Inc. for the Synthetic DNA sequences for cell culture expression of monoclonal antibodies to mumps virus. This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 41 U.S.C. 3304(a)(1). Interested persons may identify their interest and capability to respond to the requirement.
This notice of intent is not a request for competitive quotations; however, all responses received within five (5) days of the issuance of this notice will be reviewed. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. Any response should be emailed to contract specialist at iej8@cdc.gov by 1:00 p.m., Friday, July 19, 2019.
Sharon Davenport, Contract Specialist, Phone 4044272905, Email Iej8@cdc.gov
